Kindred Biosciences
(KIN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Operating Expenses | 5,026 | 6,112 | 6,460 | 7,128 | 6,912 |
| Operating Income | -5,026 | -6,112 | -6,460 | -7,128 | -6,912 |
| Other Income | 79 | 52 | 40 | 33 | 29 |
| Pre-tax Income | -4,947 | -6,060 | -6,420 | -7,095 | -6,883 |
| Net Income Continuous | -4,947 | -6,060 | -6,420 | -7,095 | -6,883 |
| Net Income | $-4,947 | $-6,060 | $-6,420 | $-7,095 | $-6,883 |
| EPS Basic Total Ops | -0.25 | -0.31 | -0.32 | -0.36 | -0.35 |
| EPS Basic Continuous Ops | -0.25 | -0.31 | -0.32 | -0.36 | -0.35 |
| EPS Diluted Total Ops | -0.25 | -0.31 | -0.32 | -0.36 | -0.35 |
| EPS Diluted Continuous Ops | -0.25 | -0.31 | -0.32 | -0.36 | -0.35 |
| EBITDA(a) | $-4,934 | $-5,997 | $-6,322 | $-7,016 | $-6,854 |